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Many studies of the immune system in human and animals
have been focused on how it protects the body from parasitic
and infectious agents [1], while, recently, many researches
were oriented on how defects in the immune system can lead
to immunopathological disorders, including autoimmune
diseases, immunodeficiencies, and hypersensitivity reactions
[1].
Many parasitic diseases are characterized by the long-
term persistence of parasites in the host, due to the not
fully effective host immunity or inadequate therapy. These
conditions have created a particular and somewhat compli-
cated host-parasite relationship supported by mechanisms of
immune evasion by parasites, such as parasites covered by
self-substances of the host, antigenic variations, and others
[2].
Moreover, the first contact between the host and the para-
site stimulates the innate immunity, the first immunological,
nonspecific mechanism for fighting against infections. This
immune response is rapid and is mediated by numerous
cells including phagocytes, T-cells, mast cells, basophils, and
eosinophils, as well as the complement system [1].
However the infection is established when innate immu-
nity failed in eliminating parasitic and infectious agents and
in that case adaptive immunity develops. The primary func-
tions of the adaptive immune response are the recognition of
specific “non-self”-antigens, the generation of immunologic
pathways for specific pathogens, and the development of an
immunologic memory [3]. The cells of the adaptive immune
system include T-cells, which are activated through the inter-
action with antigen presenting cells (APCs), and B-cells [3].
Immune mechanisms are involved in the pathology of
many parasitic infections. The main factors responsible for
the tissue injury during parasitic infections are chronicity
of the infections, release of parasites or host cells in tissues
and within the blood, alteration and destruction of the host
tissue, presence of antigenic components shared by the host
and the parasite, and relative inefficiency of the host in
eliminating the antigens or cross-reacting antibodies. The
three main pathogenic mechanisms proposed to explain
the role of infectious factors as triggers of autoimmune
diseases during parasitic infections are (1) polyclonal B- or
T-cell activation, (2) increased molecular mimicry, or (3)
immunogenicity of self-antigens secondary to the infection-
mediated inflammation [4–7].
Even though both immune mechanisms contribute to
the development of immunopathological lesions in parasitic
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diseases, in the past more attention has been given to the
humoral response, especially immune complexes and com-
plement.
Immune complexes (ICs) are formed when antibodies
bind to relevant antigens: in parasitic diseases, this can
occur at the site of parasite penetration, in the circulation,
and within tissues or organs. Normally, during the course
of the infection, the excess of ICs formed is removed by
specific cells, while in pathological conditions the release
of massive amounts of antigens from dying parasites which
can substantially influence the ratio between antigen and
antibody in favour of an antigen excess leads to high amount
of ICs that can be detrimental. Furthermore, failure of the
reticuloendothelial system to remove ICs from the blood can
be another reason of the excess of circulating ICs [7].
Circulating ICs may localize in the walls of blood vessels
or in the organs as described in the kidney during leishma-
niasis, malaria, trypanosomiasis, schistosomiasis, and other
parasitic infections. The local formation of ICs and related
diseases has been also observed in several organs such as
heart and skeletal muscle lesions in canine leishmaniasis and
others [8].
Increased levels of IgE in the host infected with different
parasites are a well-known process and they have been used
as helpful diagnostic criteria. Their significance in pathology
was usually attributed to a type I hypersensitivity reaction,
while more recent data have shown that the biological
importance of IgE includes other mechanisms [1].
Cell-mediated mechanisms of immunopathological
lesions in parasitic diseases are mainly represented by
delayed hypersensitivity reactions. A typical example is the
granulomatous reaction around eggs or parasites entrapped
in the liver, lung, gut, or intestine [9].
It is evident that immune-reactive cells including T-cells,
B-cells, and macrophages play important roles in the patho-
genesis of these immune-mediated diseases [10]. Recently, it
has been shown that several cytokines are responsible for the
development and progression of these diseases.
One example is interleukin- (IL-) 6 that is considered one
of themajor proinflammatory cytokines. It acts on a variety of
cells, including immune-competent cells and hematopoietic
cells, causing their proliferation and differentiation [11]. The
overproduction of IL-6 may be associated with many clini-
cal symptoms observed in inflammatory immune-mediated
diseases such as during leishmaniasis [12].
Based on these findings, IL-6 was thought to be a valuable
and attractive therapeutic target for drug discovery and some
research groups have developed anti-IL-6 receptor antibodies
for the treatment of patients with inflammatory autoimmune
diseases.
Based on these considerations, much attention has to be
given to the response of the immune system during parasitic
infections considering immune-mediated associated diseases
in the host and considering new targets for combined thera-
peutic approaches in such conditions.
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